Dichloroacetate causes toxic neuropathy in MELAS: a randomized, controlled clinical trial
about
Pyruvate dehydrogenase kinase as a novel therapeutic target in oncologyTreatment for mitochondrial disordersTreatment for mitochondrial disordersRole of dichloroacetate in the treatment of genetic mitochondrial diseasesDichloroacetate (DCA) as a potential metabolic-targeting therapy for cancerTargeting Cancer Metabolism - Revisiting the Warburg EffectsMitochondrial disorders in children: toward development of small-molecule treatment strategiesMitochondrial disorders: challenges in diagnosis & treatmentMetabolic dysfunction in pulmonary hypertension: the expanding relevance of the Warburg effectDichloroacetate inhibits neuroblastoma growth by specifically acting against malignant undifferentiated cellsPrenatal and postnatal expression of glutathione transferase ζ 1 in human liver and the roles of haplotype and subject age in determining activity with dichloroacetateMetabolic modulation of glioblastoma with dichloroacetateDichloroacetate causes reversible demyelination in vitro: potential mechanism for its neuropathic effectEnergy failure: does it contribute to neurodegeneration?Gene expression in a Drosophila model of mitochondrial disease.Diisopropylamine dichloroacetate, a novel pyruvate dehydrogenase kinase 4 inhibitor, as a potential therapeutic agent for metabolic disorders and multiorgan failure in severe influenzaMetabolic engineering of lactate dehydrogenase rescues mice from acidosisIntramyocellular lipid excess in the mitochondrial disorder MELAS: MRS determination at 7T.Dichloroacetate affects proliferation but not apoptosis in canine mammary cell lines.Dicumarol inhibits PDK1 and targets multiple malignant behaviors of ovarian cancer cells.Phenylbutyrate therapy for pyruvate dehydrogenase complex deficiency and lactic acidosis.Therapeutic prospects for mitochondrial disease.Phenylbutyrate increases pyruvate dehydrogenase complex activity in cells harboring a variety of defects.The neuro-ophthalmology of mitochondrial diseaseThe effect of citrulline and arginine supplementation on lactic acidemia in MELAS syndrome.The dichloroacetate dilemma: environmental hazard versus therapeutic goldmine--both or neither?Haplotype variations in glutathione transferase zeta 1 influence the kinetics and dynamics of chronic dichloroacetate in childrenA modern approach to the treatment of mitochondrial diseaseWhy are there no proven therapies for genetic mitochondrial diseases?DCA promotes progression of neuroblastoma tumors in nude mice.Mitochondrial energetics and therapeutics.Cell-permeable protein therapy for complex I dysfunctionPhase 1 trial of dichloroacetate (DCA) in adults with recurrent malignant brain tumors.Local delivery of cancer-cell glycolytic inhibitors in high-grade glioma.Mitaplatin increases sensitivity of tumor cells to cisplatin by inducing mitochondrial dysfunction.Potential compounds for the treatment of mitochondrial disease.Role and treatment of mitochondrial DNA-related mitochondrial dysfunction in sporadic neurodegenerative diseases.Differential inhibition of PDKs by phenylbutyrate and enhancement of pyruvate dehydrogenase complex activity by combination with dichloroacetateThe proline regulatory axis and cancerInterrelationships of undernutrition and neurotoxicity: food for thought and research attention.
P2860
Q21129303-6DA66ABC-A6A3-43B3-A72D-02F9821240C6Q24200432-CB51C842-187A-4E7B-9E1C-7C1BB32E0112Q24244543-88ECC317-F5DA-4B27-8CC5-233F2B7CEE76Q24630740-64E90F7B-0A16-402A-8145-8C9099E17A88Q24652941-C886604A-346B-4F33-9F13-915B9D3D9553Q26738876-C1241EC0-A840-4D60-9AF9-BBA6C8871A3AQ26767327-DA8A3281-1F90-40EA-8D4D-824A7320B195Q27000484-953EAEC6-B6EA-4640-B5E2-E007B9BF6C37Q27024293-A7B42594-91C7-4B9A-86E7-B21669594C6DQ28237181-996B810A-CF6E-4894-9505-3FAAABFF46E8Q28251446-9D0D3EF8-28AD-4CEF-8E2F-33C87E67311FQ28282255-F81028E5-A66C-4DA9-A569-0A83BE0A409DQ28284433-3AF1BF32-8A29-4F1C-B854-93D70553AC6AQ28389950-C96CFE2D-9872-49D1-9A2C-CCA99F422C78Q33523281-3CE780D7-3519-4FD8-8CA5-B8D849BE5952Q33670505-57CB4AC7-BF30-407A-A1C2-EDB360504FCAQ33713462-6BDE6325-2FF6-4D28-A53B-56FDF1CBB743Q33728887-565C0CB9-4AED-41BB-916E-F6ABA614FA03Q33773109-6D55B363-223C-4053-AC73-4F0E89C8ED5AQ33803278-8EE74118-CF82-408C-B2F9-F3D99D7B6EE9Q33918023-822E098C-F40B-487E-862C-BDABC5763778Q34205124-FC0026CB-AC09-467D-BC09-F4B6E568A6F4Q34286987-805DF8E1-80E4-4A2C-BEDB-D0770EA290E2Q34338783-37647729-12AF-49AF-BC17-1022EBA2CC6AQ34380418-BD7D8D0A-9236-4ACE-8446-648199C56B91Q34580854-EC253A31-888F-4AD8-A396-FA3E8025101AQ34771992-A165C6F0-B93E-4420-9961-C2683BC53D3FQ35011397-46EC13C8-69C7-4E17-895A-1FA4CC52CCFFQ35162928-5936DEC6-FD82-4310-9F47-5A5EA085C053Q35402620-4540248B-3B9E-487C-9B02-5A030FA8D324Q35632864-351CF36B-3C64-4692-BC5E-26E8A4711BB2Q35660914-B81C7DE5-4454-4AD6-9881-0ECA8288216AQ35684292-25C77E7D-841A-4ED3-B8C2-10A0FF9FD67EQ35788743-047A0420-EB82-4C5A-A3F9-68636038CB44Q35846798-073AB3A6-5773-4334-8BA3-DE89C464EB86Q35847813-C2ECC242-169E-4BBA-A31B-9DAAB97A1727Q35958359-F20439D6-88E3-465A-A94A-0A4DDC0CAEE1Q36001522-60EFF66F-9923-45CB-AE3A-E0DDE73046A7Q36050265-D8D117B3-CC34-4139-B147-8ECED2A2DE90Q36222137-21496551-BFB5-48A5-AED9-DAC3119F04B9
P2860
Dichloroacetate causes toxic neuropathy in MELAS: a randomized, controlled clinical trial
description
2006 nî lūn-bûn
@nan
2006 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Dichloroacetate causes toxic neuropathy in MELAS: a randomized, controlled clinical trial
@ast
Dichloroacetate causes toxic neuropathy in MELAS: a randomized, controlled clinical trial
@en
Dichloroacetate causes toxic neuropathy in MELAS: a randomized, controlled clinical trial
@nl
type
label
Dichloroacetate causes toxic neuropathy in MELAS: a randomized, controlled clinical trial
@ast
Dichloroacetate causes toxic neuropathy in MELAS: a randomized, controlled clinical trial
@en
Dichloroacetate causes toxic neuropathy in MELAS: a randomized, controlled clinical trial
@nl
prefLabel
Dichloroacetate causes toxic neuropathy in MELAS: a randomized, controlled clinical trial
@ast
Dichloroacetate causes toxic neuropathy in MELAS: a randomized, controlled clinical trial
@en
Dichloroacetate causes toxic neuropathy in MELAS: a randomized, controlled clinical trial
@nl
P2093
P3181
P1433
P1476
Dichloroacetate causes toxic neuropathy in MELAS: a randomized, controlled clinical trial
@en
P2093
De Vivo DC
Engelstad K
Kaufmann P
Pascual JM
P304
P3181
P356
10.1212/01.WNL.0000196641.05913.27
P407
P577
2006-02-01T00:00:00Z